Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

Predictions

buy
Deutsche Post AG

Start price
Target price
Perf. (%)
€36.21
09.09.22
€45.00
09.09.25
24.65%
26.01.24

buy
AXA S.A.

Start price
Target price
Perf. (%)
€24.85
09.09.22
€30.00
09.09.23
10.97%
10.09.23

buy
AXA S.A.

Start price
Target price
Perf. (%)
€24.85
09.09.22
€30.00
09.09.23
10.97%
10.09.23

buy
AXA S.A.

Start price
Target price
Perf. (%)
€24.85
09.09.22
€30.00
09.09.23
10.97%
10.09.23

buy
Koninklijke Ahold Delhaize NV

Start price
Target price
Perf. (%)
€27.86
09.09.22
€35.00
09.09.23
9.58%
30.05.23

buy
VERBIO Vereinigte BioEnergie AG

Start price
Target price
Perf. (%)
€68.85
09.09.22
€85.00
09.09.23
-11.55%
17.09.22

buy
VERBIO Vereinigte BioEnergie AG

Start price
Target price
Perf. (%)
€68.85
09.09.22
€85.00
09.09.23
-11.55%
17.09.22

buy
BYD Co. Ltd

Start price
Target price
Perf. (%)
€28.11
09.09.22
-
09.09.23
-16.99%
16.11.22

ShiftPixy Inc.

Start price
Target price
Perf. (%)
€30.74
08.09.22
-
08.09.23
-86.06%
02.04.23

Could be very worthwhile Investment >20% year
Golar LNG Ltd.

Start price
Target price
Perf. (%)
€27.60
08.09.22
€20.00
08.09.23
-26.81%
05.01.23

Could be worthwhile Investment >10% per year
Future proof or reliable business model
High valuation
Higher risks for its business
buy
Axsome Therapeutics Inc

Start price
Target price
Perf. (%)
€60.00
08.09.22
€80.00
31.12.24
35.00%
24.06.23

Could be very worthwhile Investment >20% year
buy
Vale S.A.

Start price
Target price
Perf. (%)
€12.90
08.09.22
€16.00
08.09.26
-9.36%
08.08.24

Revenue growth >5% per year expected
EBIT growth >5% per year expected
Rising EBIT margin expected
Probably not worthwhile Investment
buy
Ardelyx Inc.

Start price
Target price
Perf. (%)
€1.29
08.09.22
€2.00
31.12.24
31.25%
09.12.22

Could be very worthwhile Investment >20% year
Uniper SE

Start price
Target price
Perf. (%)
€4.65
08.09.22
€1.00
08.09.23
-17.08%
17.09.22

Below average Management
Bad culture
Little innovation
Risky Investment
buy
Bed Bath & Beyond Inc.

Start price
Target price
Perf. (%)
€7.98
08.09.22
€9.00
08.09.23
11.61%
09.09.22

Probably not worthwhile Investment
Revenue decline/stagnation expected
EBIT decline/stagnation expected
High valuation
buy
Cross Country Healthcare

Start price
Target price
Perf. (%)
€25.20
07.09.22
€30.00
07.09.23
-8.73%
07.09.23

Could be very worthwhile Investment >20% year
Revenue growth > 30% per year expected
buy
CF Industries Holdings Inc.

Start price
Target price
Perf. (%)
€102.24
07.09.22
€110.00
07.09.23
-26.21%
07.09.23

Revenue growth >5% per year expected
Could be worthwhile Investment >10% per year
buy
Devon Energy Corp.

Start price
Target price
Perf. (%)
€68.50
07.09.22
€73.00
07.09.23
-27.09%
07.09.23

Revenue growth >5% per year expected
buy
Clearfield Inc.

Start price
Target price
Perf. (%)
€99.00
07.09.22
€110.00
07.09.23
-68.59%
07.09.23

EBIT growth >5% per year expected
Revenue growth >5% per year expected
Could be worthwhile Investment >10% per year
Future proof or reliable business model
buy
Magic Software Enterprises

Start price
Target price
Perf. (%)
€16.00
07.09.22
€20.00
07.09.23
-33.75%
07.09.23

Revenue growth > 30% per year expected
Could be worthwhile Investment >10% per year
Future proof or reliable business model
Apellis Pharmaceuticals

Start price
Target price
Perf. (%)
€64.19
07.09.22
€35.00
31.12.24
8.24%
29.09.22

Could be very worthwhile Investment >20% year
Veru Inc

Start price
Target price
Perf. (%)
€11.67
07.09.22
€7.00
31.12.24
-38.34%
11.11.22

Could be very worthwhile Investment >20% year
buy
Seagen Inc.

Start price
Target price
Perf. (%)
€152.08
07.09.22
€180.00
31.12.24
21.00%
21.03.23

Could be very worthwhile Investment >20% year
buy
Seagen Inc.

Start price
Target price
Perf. (%)
€152.08
07.09.22
€180.00
31.12.24
21.00%
21.03.23

Could be very worthwhile Investment >20% year
buy
Thermo Fisher Scientific Inc.

Start price
Target price
Perf. (%)
€551.50
07.09.22
€700.00
31.12.25
-10.44%
05.05.23

Could be very worthwhile Investment >20% year